top of page


Causal AI: The Key to Tackling Complexity in Pharma
by Paul Arora Greg Myers ’ recent opinion piece  highlights the promise of artificial intelligence in reshaping drug development and...
Jan 132 min read
Â


Inka Health Partners with GIPAM GmbH to Elevate HEOR and Regulatory Science
By: Paul Arora We are thrilled to announce a strategic partnership between Inka Health and GIPAM GmbH , marking a significant milestone...
Sep 17, 20242 min read
Â


Using Synthetic Real-World Data for External Control Arm Analysis in Oncology – The ECLIPSE Study
By: Alind Gupta In the evolving landscape of clinical research, single-arm trials have become essential tools, particularly when...
Sep 12, 20243 min read
Â
bottom of page
